Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

FDA Grants Enzalutamide Priority Review for Metastatic Hormone-Sensitive Prostate Cancer

The FDA has granted a priority review designation to a supplemental new drug application for enzalutamide (Xtandi) for the treatment of men with metastatic hormone-sensitive prostate cancer.
Read More >>

Investigators Assess PARP Inhibitor-Abiraterone Combo as Frontline mCRPC Therapy

Nonmetastatic CRPC Paradigm Bursting With Influx of AR Inhibitors

Vogelzang Highlights Decades of Innovation in Prostate Cancer

Where Sipuleucel-T Fits in the Treatment of mCRPC

Olaparib Improves Radiographic PFS in HRR-Mutant mCRPC

View More Stories >>

View Conference Coverage

Charlotte Plasma Cell Disorder Congress

State of the Science Summit on Breast Cancer in Long Island

2019 International Lung Cancer Congress

2019 State of the Science Summit on Genitourinary Cancers in Jacksonville

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

Dr. Henderson on Proton Therapy Versus IMRT in Prostate Cancer

Dr. Jain on the Indications for PET Imaging in Prostate Cancer

Dr. Henderson on the Benefits of Proton Therapy in Prostate Cancer

Dr. Tan on Imaging Modalities in Prostate Cancer

Dr. George on Promise of PARP Inhibitors in Prostate Cancer

Dr. Stadler on Active Surveillance in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Cardiac Toxicity in Nonmetastatic CRPC

Management of Adverse Events in M0 CRPC

Practical Advice on Follow-Up for Patients with M0 CRPC

Benefits of Newly Approved Drugs for M0 CRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Standard of Care in Metastatic Prostate Cancer

Adverse Effects of Hormone Therapy in Prostate Cancer

The Cardioprotective Role of Androgens

Further Therapeutic Strategies in Metastatic CRPC

Practical Applications of ERA 223 in the mCRPC Paradigm

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Dr. Richardson Discusses New Directions in Multiple Myeloma

Paul G. Richardson, MD, clinical program leader and director of clinical research, Jerome Lipper Multiple Myeloma Center, and institute physician, Dana-Farber Cancer Institute, discusses new directions in multiple myeloma. View now

Priority Review Designation in GIST, Promising Findings in Bladder Cancer and NSCLC, and More